Sanofi India Ltd.

Market Capital
₹15,644 Cr.
P/E
27.32
Share Price
₹ 6839.1 46.45 (0.68%)

Sanofi India Ltd.

Quick View
₹ 6839.1 46.45 (0.68%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Company is converting accounting profit to cash
Capex vs ROCE
ROCE of the company has increased over the last three years
Share price
Share price has increased over last 10 years due to earnings
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has not sold any shares in the last 90 days
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
ROE
Latest
48.64%
3yr Average
37.87%
5yr Average
29.55%
Net Profit Margin
Latest
22.4%
3yr Average
23.6%
5yr Average
19.61%
ROCE
Latest
35.2%
3yr Average
26.66%
5yr Average
23.11%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
6.24% (as of Jul 22)
Anti - Diabetes - Market Share
0.32% (as of Jul 22)
Anti-Infectives - Market Share
0.05% (as of Mar 19)
Antineo Plastic - Market Share
1.97% (as of Jul 22)
Cardiovascular - Market Share
0.55% (as of Mar 19)
Dermatology - Market Share
1.80% (as of Jul 22)
Gastro-Intestinal - Market Share
2.67% (as of Mar 19)
Neurological - Market Share
2.87% (as of Mar 19)
Pain - Market Share
1.60% (as of Dec 22)
Pharmaceutical Sector - Market Share
3.38% (as of Mar 19)
Respiratory - Market Share
0.10% (as of Mar 19)
Sex Stimulants - Market Share
20.16% (as of Jul 22)
Vaccines - Market Share
0.12% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Allegra
    Avil
    Combiflam
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Sanofi India Ltd.
    View the discussion on ValuePickr
    timeline
    Sign Up for Free